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i:10.1016/j.ijsu.2006.09.002Abstract Adhesive small bowel obstruction is a common cause for admission to general sur-
gical wards in developed countries. Recent advances in diagnosis and management include the
use of water soluble contrast agents in the treatment and triage of patients to an operative or
conservative course, the use of CT scanning in diagnosis, the use of laparoscopy in treatment
and antiadhesion techniques to prevent recurrence.
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Adhesive small bowel obstruction (ASBO) is a common cause
for admission to surgical wards in developed countries
particularly following colorectal and pelvic surgery.1 Despite
advances in diagnosis and treatment the operative interven-
tion rate is between 15 and 30%, the recurrence rate is up
to 30% following surgery and the mortality is between 2
and 8%.1e4
Recent advances include the use ofwater soluble contrast
agents in the treatment and triage of patients to an operative
or conservative course, the use of CT scanning in diagnosis
and new antiadhesion techniques to prevent recurrence.
In this article the diagnosis, management and prevention
of ASBO is discussed and a protocol suggested for manage-
ment of this common problem.67 9482.
.co.nz
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Radiology
In the context of a clearcut clinical picture the diagnosis of
ASBO is often simple and clear cut. In the majority of such
circumstances a plain abdominal radiograph provides the
majority of the information required to secure a diagnosis.
It is very important to distinguish between small and large
bowel obstruction as the treatment is quite different. In
cases where the diagnosis is not clear other imaging may be
required. Ultrasound, MRI and CT scan are sensitive and
specific and have been recommended by some as primary
investigation tools.5,6 CT scanning can detect the cause and
site of the obstruction as well as the presence of a closed
loop.6 However, most authorities agree that a plain X-ray
is adequate in most cases and that CT scan or other modal-
ities should be reserved for situations of doubt, where
there is disparity between clinical and radiological findings,ed by Elsevier Ltd. All rights reserved.
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cess is suspected, such as neoplasm.
Our practice is to rely on the plain film except in cases of
diagnostic uncertainty. In this situation a CT scan is our
imaging modality of choice as it is easily available in our
institution.
Water soluble contrast agents
Over the last few years the use of water soluble contrast
agents has become commonplace. The most widely used
agent is Gastrografin, a mixture of sodium diatrizoate and
meglumine diatrizoate. It has a very high osmolality and
acts by drawing water into the lumen of the small bowel,
decreasing wall oedema, and by stimulating intestinal
motility. We use a dose of 100 ml administered via the
nasogastric tube as soon as the diagnosis has been made
and there is no clinical concern re strangulation or
ischaemia.
Gastrografin is used not primarily for its diagnostic
qualities but rather for its therapeutic role and as a triage
tool. The therapeutic role is probably restricted to speeding
resolution in those patients who will resolve without
operative intervention as no study has convincingly
demonstrated a difference in requirement for surgical
intervention. By way of contrast it has been demonstrated
that Gastrografin speeds resolution and decreases hospital
stay without any significant morbidity.7e10 In addition a
delayed film between 4 and 24 h after administration of
contrast will show whether or not the contrast has arrived
in the caecum.9,10 If the contrast has not arrived in
the caecum within 24 h there is a very high likelihood
that the patient will not settle with further conservative
management and these patients should be offered
surgery.7,10 In the situation where the contrast appears
in the caecum on plain X-ray the patient can be fed
and discharged when the patient is able to tolerate a
diet and has shown clear clinical evidence of resolution of
ASBO.Timing of a repeat X-ray
The timing of a repeat X-ray after Gastrografin administra-
tion is controversial. Somewhere between 4 and 24 h after
Gastrografin administration is reasonable. Four hours is the
minimum cut-off point as by this time Gastrografin has
reached the caecum in the non-obstructed patient. An
early film makes it possible for clinical decisions to be
made very early in the hospital stay. However, seventy-
five percent or more of patients will settle without surgical
intervention with Gastrografin within 24 h and thus many
patients can be spared a repeat film, and allow a trial of
conservative management, if the X-ray is delayed for
24 h.9 In the 25% of patients who have not settled at this
stage a plain abdominal film will show if the Gastrografin
has arrived in the caecum or not thus allowing a clinical
decision to be made regarding surgery or continuing conser-
vative management. Further delay beyond 24 h creates
difficulties due to dilution of the Gastrografin.
Our practice is to administer Gastrografin by the nasogas-
tric tube as soon as the diagnosis of ASBO ismade. A plain filmis taken prior to the ward round on the morning following
admission so that decisions can be made at that stage and
surgery, if required, can be planned for that day.
Detection of strangulation/ischaemia
As long as ischaemia is not present the management of
ASBO can be delayed as long as is necessary. If strangu-
lation is present the mortality from ASBO rises from 3e5%
to 30%.11 Thus early detection is vital. Clinical symptoms
and signs (continuous abdominal pain, fever, tachycardia,
peritoneal signs and leukocytosis) are neither sensitive
nor specific. Radiological findings, including those
obtained at CT scan, are not sensitive or specific for
ischaemia either. Thus the detection of ischaemia is
difficult and detection is very much a function of clinical
suspicion. In the patient in whom the above signs are
absent most surgeons are content to manage the patient
conservatively as long as the obstruction is not
complete,12 and this can be determined by the use of
Gastrografin or CT scanning as mentioned above.
If there is a clinical doubt about the diagnosis it is wise
to perform a CT scan prior to the therapeutic use of
Gastrografin as Gastrografin used undiluted in this way
makes interpretation of a CT scan virtually impossible.
Treatment
Conservative treatment
Volume resuscitation, nasogastric suction, ongoing main-
tenance fluid monitored by clinical response and close
clinical observation are the cornerstones of conservative
treatment and these have not changed for many years. If
the patient remains stable clinically then a conservative
approach can be tolerated almost indefinitely as long as
nutrition can be provided. Most clinicians arbitrarily
choose a cut-off of 48 h however but as argued above
the use of Gastrografin enables this decision to be taken
within 24 h of admission.
Surgery
For those patients who do not resolve, or in whom
ischaemia is suspected, surgery is required. This can be
performed laparoscopically or by laparotomy.13e15 Al-
though laparoscopy has been shown to be technically
feasible in ASBO the much hoped for decrease in recur-
rence rate has not yet been convincingly demonstrated.
Of more concern is a significant early reoperation rate
due to missed adhesions and inadvertent small bowel
injury occurring during adhesolysis. To avoid these
complications the first trocar must be placed using an
open approach separate to previous surgical scars and
the surgeon must have a low threshold to convert. This
technique is best suited to the patient with a single
obstructing band and is not appropriate for the patient
with several previous operations for ASBO. In the few
such selected patients laparoscopy is relatively safe and
feasible with a decrease in hospital stay and morbidity.16
In general however with a conversion rate of up to 50%14
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open approach to ASBO.
Prevention of recurrence
The recurrence rate after surgery for ASBO is 29% at
30 years and in those patients who have had 4 or more
ASBO occurrences the recurrence rate is as high as 81%.2
Thus there is significant interest in techniques that might
decrease adhesions.
A huge number of publications have addressed the
issue of preventing adhesions. A detailed review of this
subject is therefore beyond the scope of this article.
Most of the data is experimental but a few products have
been developed for clinical use.17 The most well known
are Glycerol hyaluronate/carboxymethylcellulose (Sepra-
film) and Ferric Hyaluronate gel (Intergel). These have
been the subject of a number of randomized controlled
trials. While these prevent adhesions, and decrease the
requirement for operative intervention for ASBO after
abdominal and pelvic surgery, some concerns have been
raised regarding an increase in infectious and anasto-
motic complications after intestinal resection.18e20 To
avoid these complications one study recommended
against the practice of wrapping the anastomosis or
staple line with the film.21
Apart from the use of laparoscopy for prevention of
adhesions22,23 no other techniques have found widespread
acceptance but may in time as safety and financial issues
are addressed. Some have suggested that future studies
would be most likely to show benefit in high risk groups of
patients such as total colectomy and ileostomy surgery.24
Conclusions
ASBO remains a common clinical problem. Patients
presenting with symptoms and signs consistent with
ASBO should undergo plain abdominal X-ray. If this
confirms the diagnosis, and there is no clinical suspicion
of strangulation, a water soluble contrast agent should be
administered by Nasogastric tube. The patient should be
rehydrated and a plain X-ray repeated at a time conve-
nient to the clinical team within 24 h of admission. If this
shows that the contrast has reached the caecum then, if
there is no remaining clinical concern, the patient should
be fed and discharged as soon as clinical resolution has
occurred. If the contrast has not reached the caecum it
is highly likely that the patient will not settle with con-
tinued conservative management and consideration
should be given to surgery. If diagnostic doubt remains af-
ter clinical assessment and plain X-ray a CT scan may be
helpful.
If surgery is required and the surgeon is skilled with
laparoscopy this can be considered but a low threshold for
conversion to an open approach should be maintained.
Consideration should be given to the use of an antiadhesion
product in operative cases but caution is advised if a bowel
resection is required.
Further work is required to develop antiadhesion
strategies for primary prevention of adhesions after
elective major abdominal surgery. In addition reliabletechniques for early detection of intestinal strangulation
are not yet available and further work is required to
develop these.
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